Join Type 1 Diabetes Clinical Trials Focused on Immune-Based Research and Care

Type 1 diabetes clinical trials are research studies that evaluate new investigational approaches to better understand and manage early-stage type 1 diabetes, including how the immune system affects insulin-producing cells.

Autoimmune diabetes clinical trials are generally open to individuals ages 12–35 who have been diagnosed with Stage 3 Type 1 Diabetes within the past 180 days, based on specific eligibility criteria including age, diagnosis timeline, and current health status.

The goal is to evaluate the safety, tolerability, and potential efficacy of an investigational drug that may help preserve insulin-producing cells in people recently diagnosed with Type 1 Diabetes.

Type 1 diabetes clinical trials in Houston, TX are conducted under strict clinical guidelines with continuous medical monitoring to prioritize participant safety and ethical research standards.

Participants will attend scheduled visits, receive three IV infusions of the study drug or placebo, continue their standard insulin therapy, and undergo regular health assessments including safety, immune response, and pancreatic function monitoring over approximately 13 months.

Early-stage research is important because it helps scientists better understand disease progression soon after diagnosis and supports future improvements in diabetes care and management.